Format

Send to

Choose Destination
Nat Rev Drug Discov. 2015 Apr;14(4):239-47. doi: 10.1038/nrd4503. Epub 2015 Jan 19.

A holistic approach to targeting disease with polymeric nanoparticles.

Author information

1
1] Department of Biomedical Engineering, Yale University, New Haven, Connecticut 06511, USA. Present address: Alexion Pharmaceuticals, Cheshire, Connecticut 06410, USA. [2].
2
1] Department of Biomedical Engineering, Yale University, New Haven, Connecticut 06511, USA. [2].
3
Department of Biomedical Engineering, Yale University, New Haven, Connecticut 06511, USA.

Abstract

The primary goal of nanomedicine is to improve clinical outcomes. To this end, targeted nanoparticles are engineered to reduce non-productive distribution while improving diagnostic and therapeutic efficacy. Paradoxically, as this field has matured, the notion of targeting has been minimized to the concept of increasing the affinity of a nanoparticle for its target. This Opinion article outlines a holistic view of nanoparticle targeting, in which the route of administration, molecular characteristics and temporal control of the nanoparticles are potential design variables that must be considered simultaneously. This comprehensive vision for nanoparticle targeting will facilitate the integration of nanomedicines into clinical practice.

PMID:
25598505
PMCID:
PMC4451203
DOI:
10.1038/nrd4503
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center